October 16, 2023 04:02 PM EDTUpdated 04:28 PM

Bristol Myers scores another Opdivo approval, as Merck converts AA to full approval for Keytruda in MCC

Bristol Myers Squibb on Friday nabbed another approval for its blockbuster cancer treatment Opdivo.

The drug was approved to treat patients …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Bris­tol My­ers scores an­oth­er Op­di­vo ap­proval, as Mer­ck con­verts AA to full ap­proval for Keytru­da in MCC